• Dr. Henostroza was born in Peru and did medical school at Universidad Peruana Cayetano Heredia (UPCH). Subsequently he did his internal medicine residency under John Sheagren at Illinois Masonic Medical Center. Upon finishing his residency he was offered a position back in his country to lead an initiative under the sponsorship of WHO/TDR and Find Diagnositcs to evaluate novel TB diagnostic trials, where he establish the TB Research unit at the tropical medicine institute Alexander Von Humboldt, UPCH. After this experience he continued his training in Infectious Diseases at UAB. Upon completing his fellowship he joined the ID faculty at UAB in 2008 and move with his family to live and work in Zambia a landlocked country in Sub Saharan Africa within the Center for Infectious Diseases Research in Zambia (CIDRZ), where he implemented research (funded by CDC, NIH, Stop TB partnership, European Union, USAID and AERAS) with emphasis on TB-HIV co-infection and malaria. In 2011 he was appointed Director of the UAB-Zambia Tuberculosis research Initiative. After 7 years working overseas he relocated back to Birmingham in 2015 to continue his international work now based in Birmingham. Due to his work and knowledge he serves as member of the TB diagnostic Working Group (WHO), the Prisons Working Group (IUATLD) and is a TB Advisory board member for the State of Alabama. Since 2015, Dr. Henostroza serves as Director of the Gorgas Course in Clinical Tropical Medicine (a collaborative initiative between UAB and UPCH) and more recently serves as director of William Crawford Gorgas Center for Geographic Medicine. With the sponsorship of the Gorgas Memorial Institute he oversees the Gorgas Scholarship Award, that supports international research experience for UAB medical students and residents and the UPCH-UAB Gorgas pilot grants for collaborative work within Peruvian and UAB investigators in tropical diseases. His research interest focuses on TB POC diagnostics, TB clinical trials, TB vaccine clinical trials and Health Systems Implementation in vulnerable populations with emphasis in prisoners. His current programs are currently located in Zambia, Panama, Peru and Antigua and Barbuda.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Geographic distribution and incidence of Melioidosis, Panama 2020
    2020 Obesity Affects the Association of Bioelectrical Impedance Phase Angle With Mortality in People Living With HIV 2020
    2018 Coordinating the prevention, treatment, and care continuum for HIV-associated tuberculosis in prisons: a health systems strengthening approach 2018
    2018 Phase 2b controlled trial of M72/AS01E vaccine to prevent tuberculosis 2018
    2018 The health system accountability impact of prison health committees in Zambia Stephanie Topp, Kerry Scott, Jo Hanefeld, Karen Daniels 2018
    2018 Poor continuity of care for TB diagnosis and treatment in Zambian Prisons: a situation analysis 2018
    2018 Evaluation of a health system strengthening initiative in the Zambian prison system 2018
    2018 Images in clinical tropical medicine: Ultrasound findings of plasma leakage in dengue fever 2018
    2017 Mapping the Zambian prison health system: An analysis of key structural determinants 2017
    2016 Health and healthcare access among Zambia's female prisoners: A health systems analysis 2016
    2016 High prevalence of tuberculosis in newly enrolled HIV patients in Zambia: Need for enhanced screening approach 2016
    2016 Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): A multicountry open-label randomised controlled trial 2016
    2016 Chest radiograph reading and recording system: Evaluation in frontline clinicians in Zambia 2016
    2016 Exploring the drivers of health and healthcare access in Zambian prisons: A health systems approach 2016
    2015 Spatial patterns of incident malaria cases and their household contacts in a single clinic catchment area of Chongwe District, Zambia 2015
    2015 Screening for tuberculosis and testing for human immunodeficiency virus in Zambian prisons 2015
    2014 Geographic predictors of primary multidrug-resistant tuberculosis cases in an endemic area of Lima, Peru 2014
    2014 Derivation of a tuberculosis screening rule for sub-Saharan African prisons 2014
    2014 Integrating active tuberculosis case finding in antenatal services in Zambia 2014
    2014 Managing multiple funding streams and agendas to achieve local and global health and research objectives: Lessons from the field 2014
    2013 The High Burden of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) in a Large Zambian Prison: A Public Health Alert 2013
    2013 Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa 2013
    2012 A model of tuberculosis screening for pregnant women in resource-limited settings using xpert MTB/RIF 2012
    2012 Tuberculosis and HIV control in sub-saharan african prisons: "thinking outside the prison cell" 2012
    2011 An evaluation of the performance and acceptability of three LED fluorescent microscopes in Zambia: Lessons learnt for scale-up 2011
    2010 Clinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis 2010
    2010 Durability of initial antiretroviral therapy in a resource-constrained setting and the potential need for zidovudine weight-based dosing 2010
    2008 Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries 2008
    2007 HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru 2007
    2007 Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries 2007
    2005 Incidence of and risk factors for surgical-site infections in a Peruvian hospital 2005

    Principal Investigator On

  • Epidemiology, Clinical and Microbiological Features of Patients with a Diagnosis of Tuberculosis in a Teaching Hospital of Third Level of Attention in Panama  awarded by GORGAS MEMORIAL INSTITUTE OF TROPICAL AND PREVENTIVE MEDICINE 2016 - 2019
  • HIV Vaccine Trials Network P5 Program Protocol Funding: HVTN 111  awarded by Hutchinson (Fred) Cancer Research Center 2015 - 2016
  • Efficacy of GSK Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342 against TB Disease in Healthy Adults Living in a TB Endemic Region (ZAMBIA)  awarded by Centre for Infectious Disease Research in Zambia (CIDRZ) 2015 - 2016
  • Building Capacity for Sustained Oversight and Coordination of Prison Health Services in Zambia  awarded by Centre for Infectious Disease Research in Zambia (CIDRZ) 2013 - 2016
  • Scaling Up TB Prevention, Screening, Diagnosis and Care in Zambia:Implementing the WHO 3 I's in Zambia(3I's)  awarded by Centre for Infectious Disease Research in Zambia (CIDRZ) 2012 - 2015
  • Optimizing Clinical Outcomes in HIV-Infected Adults and Children Using Xpert MTB/RIF in Zambia  awarded by Centre for Infectious Disease Research in Zambia (CIDRZ) 2012 - 2015
  • Expansion of ART, TB, and VCT Programs in Zambia  awarded by University of North Carolina at Chapel Hill 2013 - 2014
  • Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit  awarded by University of North Carolina at Chapel Hill 2012 - 2013
  • Expansion of Art, TB and VCT Programs in Zambia  awarded by University of North Carolina at Chapel Hill 2012 - 2013
  • Expansion of Art, TB and VCT Programs in Zambia  awarded by University of North Carolina at Chapel Hill 2012
  • Education And Training

  • Doctor of Medicine, 1997
  • Illinois Masonic Medical Center, Residency 2003
  • UAB Hospital, Postdoctoral Fellowship 2008
  • Full Name

  • German Henostroza